Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Allogene Therapeutics, Inc. | 198,205 | reported | 16 Mar 2026 | tx 9+623,571−25,790 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | SALE | Allogene Therapeutics, Inc. | 4,835 | 2.47 USD | |
| 02 Mar 2026 | SALE | Allogene Therapeutics, Inc. | 7,132 | 2.60 USD | |
| 02 Feb 2026 | SALE | Allogene Therapeutics, Inc. | 7,549 | 1.73 USD | |
| 02 Feb 2026 | GRANT_AWARD | Allogene Therapeutics, Inc. | 105,720 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Allogene Therapeutics, Inc. | 373,757 | 0.00 USD | deriv |
| 17 Nov 2025 | SALE | Allogene Therapeutics, Inc. | 786 | 1.22 USD | |
| 14 Mar 2025 | SALE | Allogene Therapeutics, Inc. | 5,488 | 1.98 USD | |
| 01 Mar 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 31,755 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 112,339 | 0.00 USD | deriv |